CancerPPD 2.0 - Browse by Length

Browsing by Length

Browse Results:

Filter by Year
From
Upto

ID	PMID	YEAR	Sequence	Name	Length	Linear/Cyclic	Chirality	Chem-MOD	C-ter MOD	N-ter MOD	Nature	Origin	Cell Line	Cancer Type	Assay	Activity	Testing Time	Tissue Affected	Patents
7629	37251837	2023	Not Available	CPSA-CPSC-L-ACAN	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Anticancer	Recombinant Fusion Peptide	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 63.15 μg/ml	24-h	Cervix	None
6898	34361728	2021	Structure given in figure	GA - 8	Not Available	Linear	L	None	Free	18beta-glycyrrhetinic-acid	Antimicrobial and Anticancer	Synthetic (glycyrrhetinic acid (GA)-based peptides)	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 60.70 ± 0.6 µg/mL	24-h	Colon	None
6896	34361728	2021	Structure given in figure	GA - 7	Not Available	Linear	L	None	Free	18beta-glycyrrhetinic-acid	Antimicrobial and Anticancer	Synthetic (glycyrrhetinic acid (GA)-based peptides)	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 3.30 ± 0.1 µg/mL	24-h	Liver	None
6897	34361728	2021	Structure given in figure	GA - 8	Not Available	Linear	L	None	Free	18beta-glycyrrhetinic-acid	Antimicrobial and Anticancer	Synthetic (glycyrrhetinic acid (GA)-based peptides)	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 6.90 ± 1.1 µg/mL	24-h	Breast	None
6894	34361728	2021	Structure given in figure	GA - 7	Not Available	Linear	L	None	Free	18beta-glycyrrhetinic-acid	Antimicrobial and Anticancer	Synthetic (glycyrrhetinic acid (GA)-based peptides)	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 3.70 ± 0.2 µg/mL	24-h	Breast	None
6895	34361728	2021	Structure given in figure	GA - 7	Not Available	Linear	L	None	Free	18beta-glycyrrhetinic-acid	Antimicrobial and Anticancer	Synthetic (glycyrrhetinic acid (GA)-based peptides)	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 3.0 ± 1.1 µg/mL	24-h	Colon	None
6892	34361728	2021	Structure given in figure	GA - 5	Not Available	Linear	L	None	Free	18beta-glycyrrhetinic-acid	Antimicrobial and Anticancer	Synthetic (glycyrrhetinic acid (GA)-based peptides)	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 5.0 ± 0.3 µg/mL	24-h	Breast	None
6893	34361728	2021	Structure given in figure	GA - 5	Not Available	Linear	L	None	Free	18beta-glycyrrhetinic-acid	Antimicrobial and Anticancer	Synthetic (glycyrrhetinic acid (GA)-based peptides)	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 5.2 ± 0.8 µg/mL	24-h	Colon	None
6891	34361728	2021	Structure given in figure	GA - 4	Not Available	Linear	L	None	Free	18beta-glycyrrhetinic-acid	Antimicrobial and Anticancer	Synthetic (glycyrrhetinic acid (GA)-based peptides)	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 73.0 ± 1.4 µg/mL	24-h	Colon	None
6889	34361728	2021	Structure given in figure	GA - 3	Not Available	Linear	L	None	Free	18beta-glycyrrhetinic-acid	Antimicrobial and Anticancer	Synthetic (glycyrrhetinic acid (GA)-based peptides)	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 7.40 ± 0.4 µg/mL	24-h	Colon	None
6890	34361728	2021	Structure given in figure	GA - 4	Not Available	Linear	L	None	Free	18beta-glycyrrhetinic-acid	Antimicrobial and Anticancer	Synthetic (glycyrrhetinic acid (GA)-based peptides)	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 6.10 ± 0.4 µg/mL	24-h	Breast	None
6887	34361728	2021	Structure given in figure	GA - 2	Not Available	Linear	L	None	Free	18beta-glycyrrhetinic-acid	Antimicrobial and Anticancer	Synthetic (glycyrrhetinic acid (GA)-based peptides)	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 70.30 ± 0.9 µg/mL	24-h	Colon	None
6888	34361728	2021	Structure given in figure	GA - 3	Not Available	Linear	L	None	Free	18beta-glycyrrhetinic-acid	Antimicrobial and Anticancer	Synthetic (glycyrrhetinic acid (GA)-based peptides)	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 5.1 ± 0.7 µg/mL	24-h	Breast	None
6886	34361728	2021	Structure given in figure	GA - 2	Not Available	Linear	L	None	Free	18beta-glycyrrhetinic-acid	Antimicrobial and Anticancer	Synthetic (glycyrrhetinic acid (GA)-based peptides)	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 7.70 ± 1.3 µg/mL	24-h	Breast	None
6644	33005727	2020	Not Available	LRH7-G5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Anticancer	Synthetic	HCC-1937	Breast Cancer	MTT assay	60% cell viability at 0.1 μM	48-h	Breast	None
6643	33005727	2020	Not Available	LRH7-G5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Anticancer	Synthetic	MDA-MB-231	Breast Cancer	MTT assay	60% cell viability at 0.01 μM	48-h	Breast	None
6641	32121469	2020	Figure given in Scheme 1	branched tetrapeptide Schiff bases derivative 5e	Not Available	Cyclic	L	chiral N3,N5-bis[(l-phenylalaninyl-l-leucinyl) substituted aryl or heterocyclic Schiff base]pyridine	Not Available	Not Available	Anticancer	Synthetic	MCF-7	Breast Cancer	MTT assay	IC₅₀ between 8.12 ± 0.14 to 17.55 ± 0.27 μM	NA	Breast	None
6640	32121469	2020	Figure given in Scheme 1	branched tetrapeptide Schiff bases derivative 5d	Not Available	Cyclic	L	chiral N3,N5-bis[(l-phenylalaninyl-l-leucinyl) substituted aryl or heterocyclic Schiff base]pyridine	Not Available	Not Available	Anticancer	Synthetic	MCF-7	Breast Cancer	MTT assay	IC₅₀ between 8.12 ± 0.14 to 17.55 ± 0.27 μM	NA	Breast	None
6639	32121469	2020	Figure given in Scheme 1	branched tetrapeptide Schiff bases derivative 5c	Not Available	Cyclic	L	chiral N3,N5-bis[(l-phenylalaninyl-l-leucinyl) substituted aryl or heterocyclic Schiff base]pyridine	Not Available	Not Available	Anticancer	Synthetic	MCF-7	Breast Cancer	MTT assay	IC₅₀ between 8.12 ± 0.14 to 17.55 ± 0.27 μM	NA	Breast	None
6638	32121469	2020	Figure given in Scheme 1	branched tetrapeptide Schiff bases derivative 4c	Not Available	Cyclic	L	chiral N3,N5-bis[(l-phenylalaninyl-l-leucinyl) substituted aryl or heterocyclic Schiff base]pyridine	Not Available	Not Available	Anticancer	Synthetic	MCF-7	Breast Cancer	MTT assay	IC₅₀ between 8.12 ± 0.14 to 17.55 ± 0.27 μM	NA	Breast	None
6637	32121469	2020	Figure given in Scheme 1	branched tetrapeptide Schiff bases derivative 4b	Not Available	Cyclic	L	chiral N3,N5-bis[(l-phenylalaninyl-l-leucinyl) substituted aryl or heterocyclic Schiff base]pyridine	Not Available	Not Available	Anticancer	Synthetic	MCF-7	Breast Cancer	MTT assay	IC₅₀ between 8.12 ± 0.14 to 17.55 ± 0.27 μM	NA	Breast	None
6636	32121469	2020	Figure given in Scheme 1	branched tetrapeptide Schiff bases derivative 4a	Not Available	Cyclic	L	chiral N3,N5-bis[(l-phenylalaninyl-l-leucinyl) substituted aryl or heterocyclic Schiff base]pyridine	Not Available	Not Available	Anticancer	Synthetic	MCF-7	Breast Cancer	MTT assay	IC₅₀ between 8.12 ± 0.14 to 17.55 ± 0.27 μM	NA	Breast	None
6249	31089358	2019	Not Available	ICD-85	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Anticancer	Active fractions from Gloydius halys and Hemiscorpius lepturus	MCF-7	Breast Cancer	Neutral Red Uptake assay	IC₅₀ = 21.97 ± 0.63 μg/mL	24 h	Breast	None
6248	31089358	2019	Not Available	ICD-85	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Anticancer	Active fractions from Gloydius halys and Hemiscorpius lepturus	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 36.45 ± 0.38 μg/mL	24 h	Breast	None
6235	29921888	2019	Not Available	Silk Fibroin peptide	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Anticancer	Silkworm Cocoons	LN229	Brain Tumor	MTT assay	IC₅₀ = 13.32 ± 1.15 mg/ml	72-h	Brain	None
6233	29921888	2019	Not Available	Silk Fibroin peptide	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Anticancer	Silkworm Cocoons	PC-9	Lung Cancer	MTT assay	IC₅₀ = 7.921 ± 1.19 mg/ml	72-h	Lung	None
6234	29921888	2019	Not Available	Silk Fibroin peptide	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Anticancer	Silkworm Cocoons	HT-29	Colon Cancer	MTT assay	IC₅₀ = 11.55 ± 3.33 mg/ml	72-h	Colon	None
6232	29921888	2019	Not Available	Silk Fibroin peptide	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Anticancer	Silkworm Cocoons	PANC-1	Pancreatic Cancer	MTT assay	IC₅₀ = 8.224 ± 1.43 mg/ml	72-h	Pancreas	None
6229	29921888	2019	Not Available	Silk Fibroin peptide	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Anticancer	Silkworm Cocoons	A-549	Lung Cancer	MTT assay	IC₅₀ = 9.921 ± 0.82 mg/ml	72-h	Lung	None
6230	29921888	2019	Not Available	Silk Fibroin peptide	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Anticancer	Silkworm Cocoons	H-460	Lung Cancer	MTT assay	IC₅₀ = 9.083 ± 1.22 mg/ml	72-h	Lung	None
6231	29921888	2019	Not Available	Silk Fibroin peptide	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Anticancer	Silkworm Cocoons	SW-1990	Pancreatic Cancer	MTT assay	IC₅₀ = 8.005 ± 1.34 mg/ml	72-h	Pancreas	None
5737	27218227	2017	Not Available	Tr3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Anticancer	Protein extraction from Spirulina platensis	HT-29	Colon Cancer	MTT assay	IC₅₀ = 112.89 μg/mL	48-h	Colon	None
5738	27218227	2017	Not Available	Tr4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Anticancer	Protein extraction from Spirulina platensis	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 238.86 μg/mL	48-h	Breast	None
5739	27218227	2017	Not Available	Tr4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Anticancer	Protein extraction from Spirulina platensis	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 176.37 μg/mL	48-h	Liver	None
5735	27218227	2017	Not Available	Tr2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Anticancer	Protein extraction from Spirulina platensis	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 36.42 μg/mL	48-h	Liver	None
5736	27218227	2017	Not Available	Tr2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Anticancer	Protein extraction from Spirulina platensis	SGC-7901	Gastric Cancer	MTT assay	IC₅₀ = 48.25 μg/mL	48-h	Stomach	None
5733	27218227	2017	Not Available	Tr1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Anticancer	Protein extraction from Spirulina platensis	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 147.03 μg/mL	48-h	Liver	None
5734	27218227	2017	Not Available	Tr2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Anticancer	Protein extraction from Spirulina platensis	MCF-7	Breast Cancer	MTT assay	IC₅₀ < 31.25 μg/mL	48-h	Breast	None
5732	27218227	2017	Not Available	Tr1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Anticancer	Protein extraction from Spirulina platensis	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 60.12 μg/mL	48-h	Breast	None
5725	28093334	2017	Not Available	Bothropoidin	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Antitumor and Antiangiogenic	Bothrops pauloensis snake venom	MDA-MB-231	Breast Cancer	Cell migration assay	Inhibited cell migration by 45% at 10 μg/mL	24 h	Breast	None
5723	28093334	2017	Not Available	Bothropoidin	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Antitumor and Antiangiogenic	Bothrops pauloensis snake venom	MDA-MB-231	Breast Cancer	MTT assay	30% cytotoxicity at 100 μg/mL	24 h	Breast	None
5724	28093334	2017	Not Available	Bothropoidin	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Antitumor and Antiangiogenic	Bothrops pauloensis snake venom	MDA-MB-231	Breast Cancer	Apoptosis assay	Early apoptosis at 10 μg/mL and Late apoptosis at 40 μg/mL	24 h	Breast	None
5286	27503270	2016	Not Available	Bmattacin2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Antimicrobial	silkworm Bombyx mori	HCT-116	Colorectal Cancer	MTS assay	IC₅₀ = 1.70 μM	24-h	Colon	None
5285	27503270	2016	Not Available	Bmattacin2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Antimicrobial	silkworm Bombyx mori	A-375	Skin Cancer	MTS assay	IC₅₀ = 5.23 μM	24-h	Skin	None
4675	9492845	1998	2-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N- [3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl- 1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1- yl]-5-methyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide	Dolastatin 10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Antineoplastic	Dolabella auricularia	DU-145	Prostate cancer	TUNEL assay	IC₅₀=0.5 nM	96-h	Prostate	None
4646	8445676	1993	2-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N- [3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1- (1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin- 1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3- dimethylbutanamide	Dolastatin 10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Antineoplastic	Dolabella auricularia	RL	Lymphoma Cancer	Cell Viability assay	IC₅₀=.00013-.0013 nM	Not Available	Blood	None
4647	8445676	1993	2-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N- [3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1- (1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin- 1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3- dimethylbutanamide	Dolastatin 10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Antineoplastic	Dolabella auricularia	SR	Leukemia Cancer	Cell Viability assay	IC₅₀=.0013-.013 nM	Not Available	Blood	None
4645	8445676	1993	2-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N- [3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1- (1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin- 1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3- dimethylbutanamide	Dolastatin 10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Antineoplastic	Dolabella auricularia	HT	Lymphoma Cancer	Cell Viability assay	IC₅₀=.0013-.013 nM	Not Available	Blood	None
4643	8445676	1993	VV-Nme-VPP-2-hydroxyisovaleryl-2- oxo-4-methoxy-5-benzyl-3-pyrroline	Dolastatin 15	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Antineoplastic	Dolabella auricularia	SR	Leukemia Cancer	Cell Viability assay	IC₅₀=.00013-.0013 nM	Not Available	Blood	None
4644	8445676	1993	2-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N- [3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1- (1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin- 1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3- dimethylbutanamide	Dolastatin 10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Antineoplastic	Dolabella auricularia	DB	Lymphoma Cancer	Cell Viability assay	IC₅₀=.0013-.013 nM	Not Available	Blood	None
4640	8445676	1993	VV-Nme-VPP-2-hydroxyisovaleryl-2- oxo-4-methoxy-5-benzyl-3-pyrroline	Dolastatin 15	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Antineoplastic	Dolabella auricularia	DB	Lymphoma Cancer	Cell Viability assay	IC₅₀=.00013-.0013 nM	Not Available	Blood	None
4641	8445676	1993	VV-Nme-VPP-2-hydroxyisovaleryl-2- oxo-4-methoxy-5-benzyl-3-pyrroline	Dolastatin 15	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Antineoplastic	Dolabella auricularia	HT	Lymphoma Cancer	Cell Viability assay	IC₅₀=.00013-.0013 nM	Not Available	Blood	None
4642	8445676	1993	VV-Nme-VPP-2-hydroxyisovaleryl-2- oxo-4-methoxy-5-benzyl-3-pyrroline	Dolastatin 15	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Antineoplastic	Dolabella auricularia	RL	Lymphoma Cancer	Cell Viability assay	IC₅₀=.00013-.0013 nM	Not Available	Blood	None
4218	15887970	2005	Not Available	Sansalv amide A	Not Available	Cyclic	L	None	Free	Free	Antitumor	Synthetic Peptide	S2-13	Pancreatic Cancer	Cell Viability assay	EC₅₀=7.5 µM	72-h	Pancreatic	None
4199	15835725	2004	lw	Psychrophilin D (1)	Not Available	Cyclic	D	Anthranilic acid	Free	Free	Anticancer and Antiplasmodial	Penicillium algidum	P-388	Leukemia Cancer	Cell Viability assay	ID₅₀=10.1 µg/ml	Not Available	Blood	None
3719	2387772	1989	I-C28H46N4O6, II-C27H44N4O6, III-C26H42N4O6	Cepafungin complex	Not Available	Cyclic	Not Available	None	Free	Free	Antitumor	Culture broth of strain Pseudomonas sp.	P-388	Leukemia Cancer	Not Available	NA	NA	Blood	None
3348	11943716	2002	Not Available	Hα-Defensin HNPs-2	Not Available	Not Available	Not Available	Not Available	Amidation	Not Available	Antimicrobial	Not Available	RCCs, HLA-DRB1*10301	Tumor	Cell Viability assay	Inhibition at 12.5 µg/ml	Not Available	Not Available	None
3349	11943716	2002	Not Available	Hα-Defensin HNPs-3	Not Available	Not Available	Not Available	Not Available	Amidation	Not Available	Antimicrobial	Not Available	RCCs, HLA-DRB1*10301	Tumor	Cell Viability assay	Inhibition at 12.5 µg/ml	Not Available	Not Available	None
3345	22820149	2012	Structure Given	BAA-1	Not Available	Linear	L	None	Amidation	Free	Antimicrobial	Bovine lactoferrin (Lf-B)	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀ = 8.1 µg/ml	1-h	Blood	None
3346	22820149	2012	Structure Given	BAA-2	Not Available	Linear	L	None	Amidation	Free	Antimicrobial	Bovine lactoferrin (Lf-B)	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀ = 3.8 µg/ml	8-h	Blood	None
3347	11943716	2002	Not Available	Hα-Defensin HNPs-1	Not Available	Not Available	Not Available	Not Available	Amidation	Not Available	Antimicrobial	Not Available	RCCs, HLA-DRB1*10301	Tumor	Cell Viability assay	Inhibition at 12.5 µg/ml	Not Available	Not Available	None
7842	37874670	2023	Not Available	LUNA18	Not Available	Cyclic	L	None	Free	Alkylation	Anticancer and Antitumor	Synthetic	NCI-H2122	NSCLC	CellTiter-Glo Cell Viability assay	IC₅₀ = 1.4 ± 0.3 nmol/L	Not available	Lung	None
7843	37874670	2023	Not Available	LUNA18	Not Available	Cyclic	L	None	Free	Alkylation	Anticancer and Antitumor	Synthetic	MiaPaCa.2	Pancreatic Cancer	CellTiter-Glo Cell Viability assay	IC₅₀ = 1.4 ± 0.2 nmol/L	Not available	Pancreas	None
7844	37874670	2023	Not Available	LUNA18	Not Available	Cyclic	L	None	Free	Alkylation	Anticancer and Antitumor	Synthetic	NCI-H441	NSCLC	CellTiter-Glo Cell Viability assay	IC₅₀ = 2.9 ± 0.7 nmol/L	Not available	Lung	None
7845	37874670	2023	Not Available	LUNA18	Not Available	Cyclic	L	None	Free	Alkylation	Anticancer and Antitumor	Synthetic	LS 180	Colon Cancer	CellTiter-Glo Cell Viability assay	IC₅₀ = 2.7 ± 0.4 nmol/L	Not available	Colon	None
7846	37874670	2023	Not Available	LUNA18	Not Available	Cyclic	L	None	Free	Alkylation	Anticancer and Antitumor	Synthetic	GSU	Stomach Cancer	CellTiter-Glo Cell Viability assay	IC₅₀ = 0.17 ± 0.02 nmol/L	Not available	Stomach	None
4695	20623634	2010	Not Available	Ozarelix	Not Available	Linear	L	None	Free	Free	Anticancer	LHRH antagonist	PC-3	Prostate Cancer	Cell Proliferation assay	Inhibited cell proliferation in a dose and time-dependent manner	0-96 h	Prostate	None
4696	20623634	2010	Not Available	Ozarelix	Not Available	Linear	L	None	Free	Free	Anticancer	LHRH antagonist	DU-145	Prostate Cancer	Cell Proliferation assay	Inhibited cell proliferation in a dose and time-dependent manner	0-96 h	Prostate	None